Type your tag names separated by a space and hit enter

Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis

Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis ID - 451266 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451266/all/Recombinant_interferon_beta_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -